Imagine giving fish a high-tech health insurance policy. This work creates better vaccines and natural alternatives to antibiotics to keep fish healthy without using harsh chemicals. It also uses AI and smart sensors to spot sick fish early, much like a wearable fitness tracker for a farm.
EU aquaculture faces high economic losses due to pathogens and the rising threat of antimicrobial resistance. Current husbandry practices are often not tailored to the wide variety of species and production systems used in Europe.
The project developed cost-effective vaccines, bio-based antibiotic alternatives, AI-driven digital monitoring systems, and validated Operational Welfare Indicators.
If you are a farm operator dealing with unpredictable disease outbreaks — this project developed cost-effective vaccines and AI monitoring tools that allow for earlier detection of health risks and lower fish mortality.
If you are a biotech firm dealing with the global rise of antimicrobial resistance — this project developed bio-based and sustainable alternatives to antibiotics to control pathogens across various fish life stages.
If you are a tech provider dealing with a lack of real-time health data — this project developed digital monitoring systems combining imaging and AI to track fish welfare at the farm level.
Based on available project data, specific pricing is not provided, but the project objective is to develop 'cost-effective' vaccines to ensure they are viable for EU aquaculture.
The project is currently in the development and validation phase, having co-developed Operational Welfare Indicators and digital monitoring systems, but full industrial scale-up data is not yet detailed.
Based on available project data, the project includes a specific goal to ensure the exploitation of results, though specific licensing terms are not listed in the summary.
The project focuses on developing high welfare standards that consider different life-stages and production systems to improve the resilience of EU aquaculture.
The project period runs from 2022-11-01 to 2027-04-30, indicating that results are being refined through 2027.
The consortium is heavily geared toward commercial application, with a strong industry ratio of 39% (13 industry partners, including 7 SMEs). This balance between 16 universities and 4 research institutes ensures that the scientific breakthroughs in epigenetics and vaccines are directly aligned with the practical needs of the aquaculture market across 17 countries.
Contact the Biologicke Centrum Akademie Vid Ceske Republiky in the Czech Republic
Contact us to connect with the Cure4Aqua consortium for licensing AI monitoring tools.
